Historique
Périodique
Drug-substitution treatment in Germany: a critical overview of its history, legislation and current practice
(Traitement de substitution en Allemagne : revue critique de son histoire, de sa législation et des pratiques courantes)
Auteur(s) :
GERLACH, R.
Année
2002
Page(s) :
503-521
Sous-type de document :
Etude de synthèse / Synthetic study
Langue(s) :
Anglais
ISBN :
0022-0426
Refs biblio. :
46
Domaine :
Drogues illicites / Illicit drugs
Thésaurus géographique
ALLEMAGNE
Thésaurus mots-clés
SUBSTITUTION
;
TRAITEMENT
;
HISTOIRE
;
LEGISLATION
;
OPIACES
Note générale :
Journal of Drug Issues, 2002, 32, 503-521
Résumé :
ENGLISH :
Within a global context, Germany was relatively late in its acceptance of substitution treatment, having first introduced methadone maintenance treatment (MMT) in the late 1980s. Since the early 1990s, Germany has taken a number of legal steps which favor harm reduction, assistance and treatment, rather than the law enforcement approach that was dominant before. As a result of this new commitment, Germany now also allows the use of non-methadone substitutes, such as buprenorphine, LAAM, dihydrocodeine (DHC) and codeine. A heroin maintenance trial has been scheduled to begin in early 2002. Despite the fact that the overall number of participants in drug-substitution treatment has risen over the past decade from about 1,000 in the early 1990s to more than 55,000 in 2001 and that MMT has been comprehensively evaluated in Germany with favorable outcomes, there remains a lack of availability of and accessibility to substitution treatment, due to rigid entry and treatment criteria imposed by the social health insurers (SHI). (Author's abstract.)
Affiliation :
Inst. Promotion Qualitative Drug Res., INDRO, Bremer Pl. 18-20, 48155 Münster
Allemagne. Germany.
Allemagne. Germany.